QR Code

Anti-adalimumab antibodies are associated with loss of response in juvenile idiopathic arthritis

Abstract Background Secondary drug failure to adalimumab remains a significant challenge in managing Juvenile Idiopathic Arthritis (JIA), with anti-adalimumab antibodies (ADA_ab) implicated as a potential mechanism. This study examines the relationship between ADA_ab formation and loss of response (...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Mikhail Carrim, Muhammad R. A. Shipa, Aicha Bouraoui, Toka AlSulaim, Corinne Fisher, James R. W. Glanville, Maria Leandro, Debajit Sen
Hōputu: Artigo
Reo:Inglês
I whakaputaina: BMC 2026-04-01
Rangatū:Pediatric Rheumatology Online Journal
Ngā marau:
Adalimumab
Anti-drug antibodies
Drug level
JIA
Loss of response
Drug failure
Urunga tuihono:https://doi.org/10.1186/s12969-026-01213-8
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite